| Literature DB >> 26896475 |
Timothy S Phan1, John K-J Li2, Patrick Segers3, Julio A Chirinos4.
Abstract
BACKGROUND: The hemodynamic basis for increased pulse pressure (PP) with aging remains controversial. The classic paradigm attributes a predominant role to increased pulse wave velocity (PWV) and premature wave reflections (WRs). A controversial new paradigm proposes increased forward pressure wave amplitude (FWA), attributed to proximal aortic characteristic impedance (Zc), as the predominant factor, with minor contributions from WRs. Based on theoretical considerations, we hypothesized that (rectified) WRs drive the increase in FWA, and that the forward pressure wave does not depend solely on the interaction between flow and Zc (QZc product). METHODS ANDEntities:
Keywords: arterial stiffness; characteristic impedance; forward wave amplitude; ventricular‐arterial coupling; wave reflections
Mesh:
Year: 2016 PMID: 26896475 PMCID: PMC4802482 DOI: 10.1161/JAHA.115.003069
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Asymmetric T‐tube model of the arterial system. The elastic head‐end (h) and body‐end (b) transmission tubes are characterized by characteristic impedance (Zc,h, Zc,b) and wave transmission times (τh, τb). The complex frequency‐dependent loads are characterized by distal load compliance (Cl,h, Cl,b), viscosity of vessel wall (Rd,h, Rd,b), and peripheral resistance (Rp,h, Rp,b).
Model Parameters for Modified Asymmetric T‐Tube
| Low Reflection | Control | High Reflection | |
|---|---|---|---|
| τh, ms | — | 13.5 | — |
| τb, ms | — | 22.5 | — |
| Zc,h, mm Hg·s/mL | — | 0.239 | — |
| Zc,b, mm Hg·s/mL | — | 0.200 | — |
| Zc,ao, mm Hg·s/mL | — | 0.108 | — |
| RP,h, mm Hg·s/mL | — | 4.37 | — |
| RP,b, mm Hg·s/mL | — | 1.87 | — |
| RP, mm Hg·s/mL | — | 1.31 | — |
| Cl,h, mL/mm Hg | +500% | 0.248 | −70% |
| Cl,b, mL/mm Hg | +500% | 0.825 | −70% |
Percent change is relative to control. Subscripts h and b refer to the head‐end and body‐end tubes, respectively, and ao refers to the ascending aorta. Cl indicates distal load compliance; Rp, peripheral resistance; τ, tube transit time; Zc, characteristic impedance.
Figure 2Pulsatile component of measured aortic pressure decomposed into forward (Pf) and backward (Pb) waves from the dog substudy. Reflection increases from (A) |Γ1|=0.12 to (B) |Γ1|=0.53 to (C) |Γ1|=0.76. Measured aortic flow interacting solely with Zc (QZc) is shown in dashed lines (—). The shaded red area represents the portion of Pf unexplained by Q×Zc. The vertical lines at the bottom of each panel indicate timing to peak amplitudes of the corresponding line style. All waveforms are shifted to a common origin to directly compare peak amplitudes. MTX indicates methoxamine; NTP, sodium nitroprusside.
Hemodynamic Variables Expressed as Mean±SD for n=5 Dogs
| NTP n=5 | Control n=5 | MTX n=5 |
| |
|---|---|---|---|---|
| MAP, mm Hg | 69.1±11 | 102±16 | 148±13 | <0.001 |
| SBP, mm Hg | 89.1±14 | 115±16 | 170±18 | <0.001 |
| DBP, mm Hg | 58.7±11 | 89.4±15 | 131±13 | <0.001 |
| PP, mm Hg | 30.4±7.1 | 25.9±1.1 | 38.4±6.6 | 0.013 |
| HR, bpm | 166±7.5 | 144±22 | 126±9.3 | 0.003 |
| CO, L/min | 5.08±0.83 | 3.08±0.92 | 2.53±0.78 | 0.013 |
| SVR, dyn·s/cm5 | 3067±680 | 6480±907 | 11 150±5070 | 0.004 |
| Zc, dyn·s/cm5 | 267.9±52.4 | 238.4±28.9 | 228.4±43.3 | 0.3461 |
| |Γ1| | 0.155±0.083 | 0.481±0.035 | 0.706±0.092 | <0.001 |
| θ1 (degrees) | −63.5±25 | −68.7±16 | −45.4±22 | 0.2414 |
| FWA, mm Hg | 27.8±6.2 | 20.3±1.3 | 24.2±2.9 | 0.036 |
| QZcmax, mm Hg | 25.9±6.0 | 17.6±2.3 | 15.3±3.0 | 0.004 |
|
| 0.036 | 0.004 | 0.024 | |
| tFWA, ms | 59±2.2 | 65±7.1 | 121±22 | <0.001 |
| tQmax, ms | 54±5.5 | 51±7.4 | 66±5.5 | 0.006 |
|
| 0.089 | 0.005 | 0.003 | |
| TIPf, mm Hg·s | 2.97±0.74 | 3.42±0.14 | 4.98±0.67 | <0.001 |
| TIQZc, mm Hg·s | 2.30±0.56 | 1.60±0.22 | 1.67±0.67 | 0.104 |
|
| 0.003 | <0.001 | <0.001 |
Comparisons across conditions were performed by repeated‐measures ANOVA. CO indicates cardiac output; DBP, diastolic blood pressure; FWA, forward wave amplitude; HR, heart rate; MAP, mean arterial pressure; MTX, methoxamine; NTP, sodium nitroprusside; QZc, peak aortic flow multiplied by Zc; Rp, total peripheral resistance; SBP, systolic blood pressure; tFWA, time at peak of forward wave; tQmax, time at peak flow; Γ1, global reflection coefficient magnitude at HR.
P<0.05 for control vs NTP.
P<0.05 for control vs MTX.
P<0.05 for NTP vs MTX.
Figure 3Waveforms from asymmetric T‐tube modeling of the arterial system with input of a young adult flow waveform (A through C) and older adult (D through F). Reflection increases from |Γ1|=0.14 (left column) to |Γ1|=0.42 (center column) to |Γ1|=0.70 (right column). The red shaded region indicates the portion of Pf unexplained by aortic flow interacting with Zc. The vertical lines at the bottom of each panel indicate timing to peak amplitudes of the corresponding line style. All waveforms are shifted to a common origin to directly compare peak amplitudes.
Clinical Characteristics of Study Subjects in the Human Substudy
| Clinical Sample n=193 | |
|---|---|
| Age, y | 62 (54.5–66) |
| Male sex | 178 (92.2) |
| BMI, kg/m2 | 29.8 (26.2–33.9) |
| Hypertension | 156 (80.8) |
| Current smoking | 61 (31.6) |
| Diabetes mellitus | 87 (45.1) |
| Triglycerides, mg/dL | 120 (81.0–201.0) |
| HDL‐cholesterol, mg/dL | 40 (33–48) |
| LDL‐cholesterol, mg/dL | 93 (70.5–116.0) |
| CAD | 83 (43.0) |
| HF | 84 (43.5) |
| ACE‐I use | 98 (50.1) |
| ARB use | 24 (12.4) |
| Beta‐blocker use | 113 (58.5) |
| Long‐acting nitrate use | 24 (12.4) |
| CCB use | 49 (25.4) |
Values reported as median (interquartile range) or proportions expressed in percentage. ARB indicates angiotensin receptor blocker; ACE‐I, angiotensin‐converting enzyme inhibitor; BMI, body mass index; CAD, coronary artery disease; CCB, calcium‐channel blocker; HDL, high‐density lipoprotein; HF, heart failure; LDL, low‐density lipoprotein.
Figure 4Pressure and flow waveforms from a human sample for high reflection ([A] |Γ1|=0.57; [B] |Γ1|=0.48) and low reflection ([C] |Γ1|=0.42; [D] |Γ1|=0.33). The red shaded region highlights portion of Pf unexplained by aortic flow interacting with Zc. The vertical lines at the bottom of each panel indicate timing to peak amplitudes of the corresponding line style. All waveforms are shifted to a common origin to directly compare peak amplitudes.
Hemodynamic Characteristics of Study Subjects in the Human Substudy
| Clinical Sample | |
|---|---|
| n=193 | |
| Brachial SBP, mm Hg | 140 (128, 153) |
| Brachial SBP >140 mm Hg | 92 (47.7) |
| Brachial DBP, mm Hg | 82 (74, 90) |
| MAP, mm Hg | 103 (94, 113) |
| Central SBP, mm Hg | 135 (123, 150) |
| Central PP, mm Hg | 57 (43, 65) |
| HR, bpm | 62 (56, 71) |
| CO, L/min | 5.09 (3.7, 6.5) |
| SVR, dyn·s/cm5 | 1627 (1310, 2174) |
| Zc, dyn·s/cm5 | 114 (86, 154) |
| FWA, mm Hg | 40.8 (33.5, 51.0) |
| Backward wave amplitude, mm Hg | 16.5 (13.2, 21.3) |
| |Γ1| | 0.44 (0.36, 0.51) |
| θ1 (degrees) | −48.0 (−64.3, −38.9) |
Values reported as median (interquartile range) or proportions expressed in percentage. CO indicates cardiac output; DBP, diastolic blood pressure; FWA, forward wave amplitude; HR, heart rate; MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood pressure; Γ1, global reflection coefficient magnitude at HR; Zc, characteristic impedance.
Characteristics of Human Study Subjects Divided Into Tertiles by Magnitude of Reflection (|Γ1|)
| Tertile 1 | Tertile 2 | Tertile 3 | |
|---|---|---|---|
| n=65 | n=64 | n=64 | |
| Age, y | 61 (52, 66) | 60 (54, 66) | 63 (56, 68) |
| Male sex | 60 (92.3) | 60 (93.8) | 58 (90.6) |
| BMI, kg/m2 | 31.8 (27.3, 37.0) | 29.8 (26.7, 32.8) | 28.1 (25.0, 30.2) |
| Hypertension | 51 (78.5) | 56 (87.5) | 49 (76.6) |
| Current smoking | 16 (24.6) | 22 (34.4) | 30 (46.9) |
| Diabetes mellitus | 31 (47.7) | 27 (42.2) | 29 (45.3) |
| Brachial SBP, mm Hg | 139 (126, 153) | 140 (129, 150) | 140 (129, 154) |
| Brachial SBP >140 mm Hg | 32 (49.2) | 29 (45.3) | 31 (48.4) |
| Brachial DBP, mm Hg | 82 (72, 90) | 83 (77, 90) | 82 (75, 91) |
| MAP, mm Hg | 103 (91, 115) | 103 (95, 112) | 104 (95, 115) |
| Central SBP, mm Hg | 131 (116, 148) | 135 (124, 146) | 141 (127, 156) |
| Central PP, mm Hg | 49 (39, 67) | 52 (46, 60) | 54 (45, 73) |
| HR, bpm | 70 (65, 78) | 60 (55, 67) | 59 (53, 66) |
| SVR, dyn·s/cm5 | 1410 (1179, 1846) | 1637 (1360, 1972) | 1879 (1482, 2523) |
| Zc, dyn·s/cm5 | 124 (103, 199) | 115 (91, 143) | 104 (75, 137) |
| |Γ1| | 0.33 (0.31, 0.36) | 0.44 (0.41, 0.47) | 0.54 (0.51, 0.57) |
| θ1 (degrees) | −67.4 (−83.4, −53.0) | −49.0 (−57.7, −39.9) | −36.8 (−44.7, −30.7) |
Values reported as median (interquartile range) or proportions expressed in percentage. BMI indicates body mass index; DBP, diastolic blood pressure; HR, heart rate; MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood pressure; Γ1, global reflection coefficient magnitude at HR; Zc, characteristic impedance.
Relationship Between Difference in FWA and QZcmax vs Global Reflection Parameters in the Human Substudy
| Coefficient (Standardized β) |
| |
|---|---|---|
| Model 1 ( | ||
| |Γ1| | −0.9960 (−0.0162) | 0.831 |
| θ1 (degrees) | 0.2620 (0.8684) | <0.001 |
| |Γ2| | −4.919 (−0.0858) | 0.278 |
| θ2 (degrees) | 0.01580 (0.1642) | <0.001 |
| |Γ3| | 8.885 (0.1909) | <0.001 |
| θ3 (degrees) | 0.006278 (0.1075) | 0.011 |
| Model 2 ( | ||
| θ1 (degrees) | 0.2506 (0.8309) | <0.001 |
| θ2 (degrees) | 0.01610 (0.1672) | <0.001 |
| |Γ3| | 6.348 (0.1364) | 0.005 |
| θ3 (degrees) | 0.006666 (0.1142) | 0.001 |
|Γn| and θn indicate magnitude and phase (degrees) of the nth harmonic of global reflection coefficient, respectively. FWA indicates forward wave amplitude; QZcmax, peak aortic flow multiplied by Zc.